Patents by Inventor Lies Langouche

Lies Langouche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-HYDROXYBUTYRATE ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF CRITICAL CARE TREATMENT
    Publication number: 20230310353
    Abstract: This invention relates generally to methods and compositions for the treatment or prevention of critical illness myopathy and critical illness polyneuropathy and of critical illness myopathy and critical illness polyneuropathy caused by critical illnesses including sepsis, severe sepsis, severe sepsis with septic shock, and particularly to the use of a combination of parenteral or enteral feeding with a 3-hydroxybutyrate.
    Type: Application
    Filed: April 18, 2023
    Publication date: October 5, 2023
    Inventors: Chloe Christian Goossens, Lies Langouche, Greet Van Den Berghe, Ilse Vanhorebeek
  • 3-HYDROXYBUTYRATE ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF CRITICAL CARE TREATMENT
    Publication number: 20190314307
    Abstract: This invention relates generally to methods and compositions for the treatment or prevention of critical illness myopathy and critical illness polyneuropathy and of critical illness myopathy and critical illness polyneuropathy caused by critical illnesses including sepsis, severe sepsis, severe sepsis with septic shock, and particularly to the use of a combination of parenteral or enteral feeding with a 3-hydroxybutyrate.
    Type: Application
    Filed: December 4, 2017
    Publication date: October 17, 2019
    Inventors: Chloe Goossens, Lies Langouche, Greet Van Den Berghe, Ilse Vanhorebeek
  • METHODS AND PREPARATIONS FOR PROTECTING CRITICALLY ILL PATIENTS
    Publication number: 20120015901
    Abstract: The present invention relates to a method of treating a life threatening condition in a critically ill human patient with a non-infectuous disorder, wherein the critically ill patient is a patient receiving enteral or parenteral nutrition, the method comprising the step of administering to said patient an autophagy inducing agent.
    Type: Application
    Filed: July 13, 2011
    Publication date: January 19, 2012
    Applicants: Katholieke Universiteit Leuven, K.U.Leuven R&D, Joanneum Research Forschungsgesellschaft mbH, University of Graz
    Inventors: Joris Winderickx, Greet Van Den Berghe, Jan Gunst, IIse Vanhorebeek, Lies Langouche, Tobias Eisenberg, Frank Madeo, Christophe Magnes, Frank Sinner